Comparison of Combined Venous and Arterial Thrombolysis with Primary Arterial Therapy Using Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 3, 2008, Pages 121-128

  Wolfe, Thomas ^a   Suarez, Jose I ^b   Tarr, Robert W ^b   Welter, Elisabeth ^b   Landis, Dennis ^b   Sunshine, Jeffrey L ^b   Zaidat, Osama O ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

acute stroke; Cerebrovascular; combination therapy; endovascular; ischemic stroke; recombinant tissue plasminogen activator; thrombolytics

Indexed keywords

ALTEPLASE; HEPARIN;

ACUTE DISEASE; ADULT; ARTICLE; BIVARIATE ANALYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECANALIZATION; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RISK ASSESSMENT; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 43049118612     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2007.12.004     Document Type: Article

References (23)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Furlan A., Higashida R., Weschler L., et al., PROACT II Investigators. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study, a randomized controlled trial. JAMA 282 (1999) 2003-2011
3. del Zoppo G.J., Higashida R.T., Furlan A.J., et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke; PROACT investigators, prolyse in acute cerebral thromboembolism. Stroke 29 (1998) 4-11
4. Suarez J.I., Sunshine J.L., Tarr R., et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30 (1999) 2094-2100
5. The IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 35 (2004) 904-912
6. Lewandowski C., Frankel M., Tomsick T., et al., EMS Bridging Trial Investigators. Combined intravenous and intra-arterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency management of stroke (EMS) bridging trial. Stroke 30 (1999) 2598-2605
7. Zaidat O.O., Welter E., Love T.E., et al. Combined intra-venous and intra-arterial versus intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke patients: Propensity score analysis. J Neurosurg 100 (2004) A181 (abstr)
8. Ernst R., Pancioli A., Tomsick T., et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 31 (2000) 2552-2557
9. Zaidat O.O., Suarez J.I., Santillan C., et al. Intrarterial and combined intravenous and intra-arterial thrombolytic therapy for distal carotid artery occlusion. Stroke 33 (2002) 1828-1833
10. Suarez J.I., Zaidat O.O., Sunshine J.L., et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50 (2002) 251-260
11. Qureshi A.I., Siddiqui A.M., Suri M.F., et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery 51 (2002) 1319-1329
12. The MERCI Investigators. Results of the combined MERCI I-II (mechanical embolus removal in cerebral ischemia) trials. Stroke 35 (2004) 240 (abstr)
13. Marler J., Tilley B., Lu M., et al. Earlier treatment associated with better outcome in the NINDS TPA stroke study. Stroke 30 (1999) 244 (abstr)
14. NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA stroke trial. Stroke 28 (1997) 2119-2125
15. NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28 (1997) 2109-2118
16. Marler J.R., Tilley B.C., Lu M., et al. Early stroke treatment associated with better outcome: The NINDS rt-PA stroke study. Neurology 55 (2000) 1649-1655
17. Brott T.G., Haley Jr. E.C., Levy D.E., et al. Urgent therapy for stroke, I: Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23 (1992) 632-640
18. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
19. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
20. Sunshine J.L., Tarr R.W., Lanzieri C.F., et al. Hyperacute stroke: Ultrafast MR imaging to triage patients prior to therapy. Radiology 212 (1999) 325-332
21. Tong D.C., and Albers G.W. Diffusion and perfusion magnetic resonance imaging for the evaluation of acute stroke: Potential use in guiding thrombolytic therapy. Curr Opin Neurol 13 (2000) 45-50
22. Wolpert S., Bruckman H., Greenlee R., et al., rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator: The rt-PA acute stroke study group. AJNR Am J Neuroradiol 14 (1993) 3-13
23. IMS II Trial Investigators. The interventional management of stroke (IMS) II study. Stroke 38 (2007) 2127-2135